Abstract
In rheumatic patients candidate to anti-TNF-alpha treatment, there is an increased risk of developing tuberculosis (TB). The tuberculin skin test (TST), the standard diagnostic test for latent tuberculosis infection (LTBI), suffers low specificity and sensitivity. Here, we compared the performance characteristics of an in-house ELISPOT-IFN-gamma assay (using a restricted pool of Mycobacterium tuberculosis-specific peptides or MTP) to TST for the diagnosis of LTBI in 69 rheumatic patients candidate to anti-TNF-alpha treatment and in 60 healthy LTBI individuals. Among the 69 patients enrolled, 17 (25%) had a positive TST response and 15 (22%) a positive ELISPOT-MTP response. Among the patients with a positive TST result, eight had a positive and nine a negative ELISPOT-MTP response, whereas among the 49 patients with a negative TST result, 42 were ELISPOT-MTP negative, but seven (14%) were ELISPOT-MTP positive, with three indeterminate results. The agreement between the two tests was poor (k = 0.341, 95% CI = 0.060 to 0.622) and the test of symmetry was not significant (P = 0.8). Considering the ELISPOT assay, rheumatic patients had a reduced number of spot-forming cells after stimulation of lymphocytes with PHA or PPD when compa...Continue Reading
References
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine
May 19, 2000·Infection and Immunity·S M ArendT H Ottenhoff
May 24, 2000·The Journal of Infectious Diseases·S M ArendT H Ottenhoff
Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun
Oct 16, 2002·Annals of the Rheumatic Diseases·D E FurstR Kurth
Mar 5, 2003·The Lancet Infectious Diseases·Michael A GardamDonald C Vinh
Jul 16, 2003·Annals of the Rheumatic Diseases·X Mariette, D Salmon
Aug 9, 2003·Arthritis and Rheumatism·Juan J Gómez-ReinoUNKNOWN BIOBADASER Group
Aug 7, 2004·Journal of Clinical Microbiology·Paolo ScarpelliniClaudio Fortis
Nov 30, 2004·The Lancet Infectious Diseases·Madhukar PaiJohn M Colford
Jun 4, 2005·Arthritis and Rheumatism·Loreto CarmonaUNKNOWN BIOBADASER Group
May 3, 2006·Respiratory Medicine·Heinke Kunst
Jun 8, 2006·Journal of Clinical Microbiology·Luigi CodecasaClaudio Fortis
Aug 18, 2006·The New England Journal of Medicine·D L Scott, G H Kingsley
Jan 11, 2007·Clinical Medicine & Research·Paola ManteganiClaudio Fortis
Apr 26, 2007·Annals of the Rheumatic Diseases·Jérémie SellamUNKNOWN RATIO (Research Axed on Tolerance of Biotherapies) Study Group
May 16, 2007·Rheumatology International·Hiroki TakahashiKohzoh Imai
Jul 24, 2007·Annals of the Rheumatic Diseases·G MatulisS D Gadola
Aug 8, 2007·Clinical and Experimental Immunology·D VincentiD Goletti
Dec 7, 2007·The European Respiratory Journal·P BeffaJ-P Zellweger
Dec 26, 2007·The Journal of Experimental Medicine·Andrea J WolfJoel D Ernst
Jan 23, 2008·Rheumatology·R DinserM Sester
May 13, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M BocchinoA Sanduzzi
Jun 3, 2008·Arthritis and Rheumatism·Der-Yuan ChenJoung-Liang Lan
Aug 8, 2008·The American Journal of Gastroenterology·Alain M SchoepferFrank Seibold
Aug 13, 2008·Journal of the American Academy of Dermatology·Claudia HernandezJune K Robinson
Aug 19, 2008·Autoimmunity Reviews·Ajit Lalvani, Kerry A Millington
Jan 30, 2009·Annals of the Rheumatic Diseases·J MartinB Bresnihan
Feb 13, 2009·Tuberculosis·Shuji MurakamiYoshiaki Ishigatsubo
Feb 21, 2009·The Journal of Rheumatology·Samuel M BeharMichael E Weinblatt